Formulary

BrightEssence Cream

February 1, 2006


Phase A
Dow Corning 9011 (Cyclopentasiloxane [and] PEG-12 dimethicone crosspolymer)
11.20
Dow Corning 345 fluid (Cyclomethicone)
11.90
Dow Corning 1501 (Cyclopentasiloxane [and] dimethiconol)
1.70
Dub IPM (Stearinerie Dubois Fils) (Isopropyl myristate)
6.70
Dekaben (Jan Dekker) (Phenoxyethanol [and] methylparaben [and] ethylparaben [and] butylparaben [and] isobutylparaben [and] propylparaben)
0.50
Z-Cote HP-1 (BASF Corp.) (Zinc oxide [and] dimethicone)
1.00
Perfume (Pirouette/Firmenich)
0.40

Phase B
Water
53.00
Glycerin
2.50
Alpha arbutin (Pentapharm)
1.00
Trivalin SF (S. Black) (Ethoxydiglycol)
5.00

Phase C
Dow Corning Trefil E-506 S (Dimethicone/vinyl dimethicone crosspolymer)
4.10
Ronasphere (Merck KgaA) (Silica)
1.00

Procedure
Mix Dow Corning 9011 and Dow Corning 345 with Z-Cote using ultra-turrax until homogeneous. Mix rest of phase A and add Z-Cote HP-1 premix. Mix ingredients of phase B together and slowly add to phase A with moderate stirring. Mix for five minutes. Prepare a premix of phase C by mixing the ingredients in a coffee grinder until a flowing powder mix is obtained. Spread the powder mix into the formulation while stirring and increase stirring speed to 1,300 rpm. Homogenize using ultra-turrax at 15,000 rpm for at least one minute.

More Information
Dow Corning, PO Box 994, Midland, MI 48686-0994
Tel: (989) 496-4000; Fax: (989) 496-4586
E-mail: info@dowcorning.com; Website: www.dowcorning.com
blog comments powered by Disqus
  • Who Makes That?

    Who Makes That?

    Tom Branna, Editorial Director||April 1, 2016
    From concept and formulation to testing and filling, today’s contract manufacturers perform a range of services for marketers

  • Multi-Cultural Beauty Update

    Multi-Cultural Beauty Update

    Christine Esposito, Associate Editor||April 1, 2016
    Established brands and start-ups address the needs of multi-cultural beauty consumers.

  • The Scalp Microbiome

    The Scalp Microbiome

    Nava Dayan PhD, Dr. Nava Dayan LLC||April 1, 2016
    A review of recent findings and innovative approaches for treating scalp disorders.